Patients typically see: 4% body weight reduction after two months 6% reduction after three months 8% reduction after four months Long-term Results (Beyond Week 20) Extended treatment shows impressive outcomes: Average weight loss of 15% by month 17 Sustained results through continued treatment Improved metabolic health markers You should take a missed dose within five days for the best results
At 510x the price of generics, it remains to be seen whether brand alone can defend the premium
Whilst there is no absolute contraindication, initiation should involve specialist cardiology input and close monitoring
Inadequate fluid intake : Some individuals taking Semaglutide may eat or drink less due to nausea or loss of appetite
Lefebvre P, Letois F, Sultan A, Nocca D, Mura T, Galtier F
It is essential to emphasise that any use of GLP-1 medications in Hashimoto's patients would be off-label unless the individual also meets criteria for type 2 diabetes or obesity treatment according to the medication's SmPC
